Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q3 2024 Revenue Cycle Management Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q3 2024 Revenue Cycle Management Update

In Q3 2024, M&A activity in RCM remained robust, attracting considerable interest from private equity and strategic buyers. Increasing labor and supply costs, along with complex billing procedures and a heightened emphasis on patient experience, have amplified the demand for RCM services so far this year. This has allowed established RCM platforms to leverage their existing technologies and client bases to enhance operational efficiencies of potential acquisition targets.

Although the RCM market has experienced some consolidation, it remains largely fragmented, providing ample opportunities for private equity and strategic operators to invest. As these players look to increase their market share, they may pursue additional technology acquisitions or expand into new specialties. Provident anticipates that as more platforms explore M&A options in the coming months, the demand for differentiated RCM providers will lead to higher valuations and a focus on innovative growth strategies.

To print and download the full Revenue Cycle Management Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/10/Q3-2024-RCM-Newsletter_vP.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]